Intraocular ASC payments
This article was originally published in The Gray Sheet
Executive Summary
CMS should reduce payments for IOLs based on lens material, according to an 1HHS Office of Inspector General report. The document finds that the current $150 ambulatory surgical center payment rate overpays for the intraocular lenses, since the "highest cost" soft acrylic, "most frequently used" silicone and "lowest cost" PMMA IOL lenses have respective average costs of $125, $69 and $39, based on claims data for the 12 months ending June 2002. CMS has agreed to take the report into account when it revamps the ASC system, as required by the Medicare reform law...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.